loading

Perspective Therapeutics Inc (CATX) 最新ニュース

Salarius Pharmaceuticals (NASDAQ:SLRX) Shares to Reverse Split on Monday, June 17th - Defense World

pulisher
Defense World

Corbus Pharmaceuticals (NASDAQ:CRBP) Hits New 1-Year High Following Analyst Upgrade - Defense World

pulisher
Defense World

There is no way Perspective Therapeutics Inc (CATX) can keep these numbers up – Sete News - SETE News

pulisher
SETE News

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index - ForexTV.com

pulisher
ForexTV.com

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index

pulisher
GlobeNewswire Inc.

Taking a Closer Look At Perspective Therapeutics Inc (CATX) Following Its Recent Trade – Knox Daily - Knox Daily

pulisher
Knox Daily

Taking a Closer Look At Perspective Therapeutics Inc (CATX) Following Its Recent Trade – Knox Daily - Knox Daily

pulisher
Knox Daily

Perspective Therapeutics Inc: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

pulisher
The InvestChronicle

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting - ForexTV.com

pulisher
ForexTV.com

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

pulisher
GlobeNewswire Inc.

Understanding CATX's financial ratios: A beginner's guide – US Post News - US Post News

pulisher
US Post News

Market Momentum: Perspective Therapeutics Inc (CATX) Registers a -6.98 Decrease, Closing at 1.20 – DWinneX - The Dwinnex

pulisher
The Dwinnex

Kintara Therapeutics Inc Inc. (KTRA) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

pulisher
The InvestChronicle

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of “Buy” from Brokerages - Defense World

pulisher
Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Receives $1.90 Average Price Target from Analysts - MarketBeat

pulisher
MarketBeat

Expensify And 2 Other Stocks Under $2 Insiders Are Buying - MSN

pulisher
MSN

Perspective Therapeutics Inc [AMEX: CATX] Sees Increase in Stock Value – Knox Daily - Knox Daily

pulisher
Knox Daily

Spero Therapeutics (NASDAQ:SPRO) Stock Passes Below Two Hundred Day Moving Average of $1.50 - Defense World

pulisher
Defense World

Perspective Therapeutics' $80 Million Shares Offering – Global Legal Chronicle - Global Legal Chronicle

pulisher
Global Legal Chronicle

Expensify And 2 Other Stocks Under $2 Insiders Are Buying - MSN

pulisher
MSN

Perspective Therapeutics, Inc. (NYSE:CATX) Director Lori A. Woods Buys 34246 Shares of Stock - Defense World

pulisher
Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Director Robert F. Williamson III Acquires 55000 Shares - Defense World

pulisher
Defense World

Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com Nigeria

pulisher
Investing.com Nigeria

Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Perspective therapeutics director Lori Woods buys $49.9k in stock - Investing.com India

pulisher
Investing.com India

Perspective therapeutics director Lori Woods buys $49.9k in stock By Investing.com - Investing.com

pulisher
Investing.com

Perspective Therapeutics, Inc. (NYSE:CATX) CFO Jonathan Robert Hunt Purchases 25006 Shares of Stock - Defense World

pulisher
Defense World

CATX Stock Earnings: Perspective Therapeutics Meets EPS for Q1 2024 - MSN

pulisher
MSN

Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities - Legal Desire News Network

pulisher
Legal Desire News Network

CATX’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

pulisher
The InvestChronicle

Expensify And 2 Other Stocks Under $2 Insiders Are Buying - Expensify (NASDAQ:EXFY) - Benzinga

pulisher
Benzinga

Expensify And 2 Other Stocks Under $2 Insiders Are Buying By Benzinga - Investing.com UK

pulisher
Investing.com UK

Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities - Legal Desire News Network

pulisher
Legal Desire News Network

Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Expensify And 2 Other Stocks Under $2 Insiders Are Buying - Expensify (NASDAQ:EXFY) - Benzinga

pulisher
Benzinga

Perspective therapeutics director buys $75.9k in company stock - Investing.com South Africa

pulisher
Investing.com South Africa

CFO of Perspective Therapeutics buys $35,007 in company stock By Investing.com - Investing.com

pulisher
Investing.com

CFO of Perspective Therapeutics buys $35,007 in company stock By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Perspective Therapeutics, Inc. (NYSE:CATX) CFO Buys $35,008.40 in Stock - MarketBeat

pulisher
MarketBeat

Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com

pulisher
Investing.com

Avalon GloboCare Corp. (NASDAQ: ALBT) surges Over 300% Amid Promotional Activity and NASDAQ Compliance ... - BP Journal

pulisher
BP Journal

Perspective therapeutics director buys $75.9k in company stock By Investing.com - Investing.com UK

pulisher
Investing.com UK

Daily Progress: Perspective Therapeutics Inc (CATX) Gain 4.55, Closing at 1.38 – DWinneX - The Dwinnex

pulisher
The Dwinnex

Monitoring Perspective Therapeutics Inc (CATX) after recent insider movements – Knox Daily - Knox Daily

pulisher
Knox Daily

Have you been able to find a good deal on Perspective Therapeutics Inc's shares? – US Post News - US Post News

pulisher
US Post News

How does Perspective Therapeutics Inc (CATX) change from a tortoise to a hare? – Sete News - SETE News

pulisher
SETE News

Perspective Therapeutics, Inc. (NYSE:CATX) CFO Buys $35,008.40 in Stock - MarketBeat

pulisher
MarketBeat

Insider Buying: Perspective Therapeutics, Inc. (NYSE:CATX) Director Purchases $39941.23 in Stock - Defense World

pulisher
Defense World
$265.20
price up icon 4.30%
medical_devices ZBH
$107.45
price down icon 1.63%
medical_devices STE
$222.98
price down icon 1.04%
medical_devices PHG
$26.14
price down icon 0.42%
$113.75
price down icon 2.03%
medical_devices EW
$87.41
price down icon 0.81%
大文字化:     |  ボリューム (24 時間):